GEA
ABMD

Glen Eagle Advisors’s Abiomed Inc ABMD Stock Holding History

Glen Eagle Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-170
Closed -$41.8K – 1182
2022
Q3 		$41.8K Hold
170
– – 0.01% 373
2022
Q2 		$42.1K Hold
170
– – 0.01% 390
2022
Q1 		$56.3K Sell
170
-30
-15% -$9.23K 0.01% 361
2021
Q4 		$71.8K Hold
200
– – 0.02% 322
2021
Q3 		$65.1K Hold
200
– – 0.02% 334
2021
Q2 		$62.4K Hold
200
– – 0.02% 338
2021
Q1 		$63.7K Hold
200
– – 0.02% 308
2020
Q4 		$64.8K Hold
200
– – 0.03% 290
2020
Q3 		$55.4K Hold
200
– – 0.02% 290
2020
Q2 		$48.3K Hold
200
– – 0.02% 292
2020
Q1 		$29K Hold
200
– – 0.02% 340
2019
Q4 		$34.1K Hold
200
– – 0.02% 372
2019
Q3 		$35.6K Hold
200
– – 0.02% 328
2019
Q2 		$52.1K Hold
200
– – 0.04% 274
2019
Q1 		$57.1K Hold
200
– – 0.04% 258
2018
Q4 		$65K Hold
200
– – 0.05% 222
2018
Q3 		$90K Hold
200
– – 0.06% 213
2018
Q2 		$81.8K Hold
200
– – 0.06% 217
2018
Q1 		$58.2K Buy
+200
New +$50.7K 0.05% 234
2017
Q4 		– Sell
-200
Closed -$33.7K – 680
2017
Q3 		$33.7K Buy
+200
New +$30.2K 0.03% 278

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Glen Eagle Advisors's ABMD Position: Q4 2022 in Review

Glen Eagle Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 170 shares — an estimated $41.8K sold.

Glen Eagle Advisors first reported a position in ABMD in Q3 2017 and held it in 20 quarters. The position peaked at $90K in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Glen Eagle Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Glen Eagle Advisors sold 170 Abiomed Inc shares in Q4 2022, an estimated $41.8K.
  • Glen Eagle Advisors first reported a position in Abiomed Inc in Q3 2017 and held it in 20 quarters.
  • Glen Eagle Advisors's Abiomed Inc position peaked at $90K in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Glen Eagle Advisors's 13F filing for Q4 2022, filed 13 Aug 2024.